RANI BUI: Open Payments
NPI 1679347843 · TUALATIN, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $437 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $244 |
| Galderma Laboratories, L.P. | 2 | $232 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $108 |
| UCB, Inc. | 4 | $99 |
| Arcutis Biotherapeutics, Inc. | 1 | $90 |
| ABBVIE INC. | 3 | $64 |
| Lilly USA, LLC | 1 | $25 |
| Incyte Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: DUPIXENT, NEMLUVIO, Cabtreo, TREMFYA, Bimzelx, Zoryve, SKYRIZI, TALTZ.
Industry payments across OR — which companies pay providers there.
